StreetAlpha.app
Home › Stocks › STAA

Staar Surgical Co (STAA)

Healthcare
$25.56
▼ −1.73%
LAST CLOSE · NOV 17

STAAR Surgical makes implantable lenses used in eye surgery to correct vision problems such as nearsightedness. It last closed at $25.56 on Nov 17, down 1.73% on the day. STAA last reported earnings on Wed, Aug 12, 2026.

AI Auto Pilots
Is STAA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$328.3M
+42.4% vs a year ago
Net income
$530K
0.2% margin
EPS (diluted)
$0.01
Free cash flow
$17.8M
5.4% margin
Valuation
Market cap
$1.3B
50.2M shares
P/E
2556.0
Price over 12 month EPS
Price to sales
3.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$133.6M
At Oct 2
Shareholder equity
$376.1M
Shares outstanding
50.2M
At Oct 30
Fiscal year endsJanuary
ExchangeNasdaq
Financials history
FY2021: $230.5M$230.5MFY2021FY2022: $239.4M$239.4MFY2022FY2023: $322.4M$322.4MFY2023FY2024: $313.9M$313.9MFY2024FY2026: $239.4M$239.4MFY2026

From STAA's SEC filings, latest 10-Q for the period ending Oct 2, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Last report
Aug 12
2026 · After the close (AMC)
Reported EPS
$0.18
vs $0.05 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±10.2%
Priced in before that report
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated STAA in the past 90 days, not enough for a consensus
Average 12-month target
$23.00
▼ 10.0% downside

Based on 1 analyst who set a price target on STAA in the past 90 days. The average target is $23.00, with a high of $23.00 and a low of $23.00, compared with the last close of $25.56.

Low $23.00Avg $23.00High $23.00
Blue marker: last close $25.56
Highest target$23.00
Average target$23.00
Lowest target$23.00
Latest rating changes
JefferiesMaintained
Sep 22Buy$23
StifelMaintained
Aug 17Hold$28
UBSTarget lowered
Aug 13Sell$20 → $19
WedbushTarget lowered
Aug 13Buy$40 → $37
UBSInitiated
Jul 28Sell$20
DateFirmActionRatingPrice target
Sep 22JefferiesMaintainedBuy$23
Aug 17StifelMaintainedHold$28
Aug 13UBSTarget loweredSell$20 → $19
Aug 13WedbushTarget loweredBuy$40 → $37
Jul 28UBSInitiatedSell$20
Loading…

Technical Analysis

STAA · as of the Nov 17 close · updated after every close
Uptrend

The stock is 3% above its 20 day and 10% above its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 55). The nearest support is the Pivot S1 at $25.20, and the nearest resistance the Pivot R1 at $25.93.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 4.9%/day
Key levels
$35.8752 week high+40.3%
$26.25Swing high (Aug 14)+2.7%
$25.93Pivot R1+1.4%
$25.56Pivot+0.0%
$25.56Last close
$25.20Pivot S1−1.4%
$24.8820 day average−2.7%
$24.01100 day average−6.1%
$23.97200 day average−6.2%
$23.28Swing low (Nov 10)−8.9%
$23.0550 day average−9.8%
$15.5952 week low−39.0%
Indicators
RSI (14)55.37Middle of its rangeNeutral
MACD0.89Above its signal lineBullish
Stochastic43.7Middle of its rangeNeutral
ADX (14)30.2Trending up
Williams %R-63.8Oversold below −80, overbought above −20Neutral
CCI (20)39.4Oversold below −100, overbought above 100Neutral
Rate of change+1.6%Change over 10 sessionsBullish
ATR (14)$1.24Typical daily range, 4.9% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for STAA

What happened before

See how STAA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow STAA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How STAA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in STAA in the last 90 days.

Loading…

See today’s whale options flow across the market →

STAA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼92 buying vs 107 selling
  • ▼Held by funds -9.5 pts
  • ▼Funds holding -5
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding197202−2.5%
In funds' top 1036−50.0%
Held by funds100.5%110.0%−9.5 pts
New / increased34 / 5846 / 59−12.4%
Reduced / sold out65 / 4255 / 32+23.0%
Put/call ratio0.840.87−2.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See STAA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STAA is in one of them and how their past STAA trades turned out.

STAA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered STAA in an article yet. Here's the latest on the wider market.

STAA Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Sep 22
Who traded STAA · since 2026
Latest 1 filing
$1K – $15KTraded Jul 29, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$1K – $15KJul 29, 2026Sep 22, 202655 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Staar Surgical

STAAR Surgical designs and makes implantable lenses that are placed inside the eye during refractive surgery to correct vision. Its main product is the Implantable Collamer Lens, used to treat nearsightedness, farsightedness and astigmatism. The company sells its lenses to eye surgeons and patients in many countries, and most of its revenue comes from outside the United States. It is based in Monrovia, California.

Headquarters
Monrovia, CA